New Delhi [India], March 26 (ANI): Union Health Ministry informed that the cumulative number of COVID-19 vaccine doses administered in the country has crossed 5.69 crores on Friday.
New Delhi [India], March 25 (ANI): RS Sharma, Chairman, Empowered Group on COVID vaccination informed that now CoWIN does not schedule second dose vaccination appointment automatically.
New Delhi [India], March 22 (ANI): The cumulative number of COVID-19 vaccine doses administered in the country has crossed 4.72 crore with 19,65,635 doses being given on Monday, the Union Health Ministry said.
Port Louis [Mauritius], March 19 (ANI): In a unified attempt to free the world of coronavirus, India on Friday handed over to Mauritius a commercial supply of 200,000 doses of Covaxin vaccines under the 'Vaccine Maitri' initiative.
Port Louis [Mauritius], March 19 (ANI): Mauritius will receive a consignment of Covaxin, India's indigenously developed COVID-19 vaccine, on Friday, announced the High Commission of India in Port Louis on Thursday.
New Delhi [India], March 17 (ANI): Ambassadors of Paraguay and Costa Rica have hailed India's initiative to supply vaccines to other countries as part of efforts to fight the COVID-19 crisis and said they were looking forward to getting India-made vaccines.
New Delhi [India], March 17 (ANI): External Affairs Minister S Jaishankar on Wednesday said he was proud to have taken 'Covaxin' and recalled that questions were raised when the indigenous COVID-19 vaccine manufactured by Bharat Biotech came to the market earlier this year.
New Delhi [India], March 10 (ANI): The Subject expert committee (SEC) of Drugs Controller General of India (DCGI) on Wednesday recommended removing the "clinical trial mode" condition related to Bharat Biotech's Covaxin.
New Delhi [India], March 9 (ANI): British medical journal The Lancet on Tuesday published the phase 2 results of the "Made in India" COVID-19 vaccine, COVAXIN, stating that the vaccine has better reactogenicity and safety outcomes, and enhanced humoral and cell-mediated immune responses c